EMA executive director sets out five year vision

The new executive director of the European Medicines Agency has outlined his vision for the next five years saying he is ‘ready to address the challenges ahead.’

Speaking at a press briefing, Guido Rasi set out his main priorities which include a renewed focus on research and development of medicines, patient involvement and a commitment to transparency.

He said: “We want to focus our efforts on medicines which have the potential to really improve patients’ lives so that innovation really translates into health benefits. All that we do must ultimately benefit patients. This is why we involve them more and more in our work, to ensure their views and needs are taken into account at every step of the process.”